Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: Death NOS; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) regulatory authority, regulatory authority report number FR-AFSSAPS-BX20210769. A 94-year-old male patient received first dose of bnt162b2 (COMIRNATY, lot number: EJ6788), intramuscularly on left arm on 26Jan2021 at single dose for COVID-19 immunization, oxazepam (SERESTA) orally from 04Feb2021 to 06Feb2021 at 10 mg, twice daily for anxiety attack. Medical history included asthma , had Covid-19 (Test on 21Oct2020), dementia, hypertension arterial, chronic obstructive pulmonary disease, patient in an institution who recently lost his wife, increased ambulation and anxiety before the vaccination, significant anxiety crisis on 04Feb2021. In this context, treatment with oxazepam 10 mg twice a day for two days. No psychotropic treatment. The patient''s concomitant medications were not reported. The patient was found dead in bed on 06Feb2021 04:15 am. The action taken in response to the event for oxazepam was not applicable. The patient died on 06Feb2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected. ; Reported Cause(s) of Death: Death NOS
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166